Park Square places Melissa Bradford-Klug as Chief Business Officer at Citrine Medicine Ltd.

Park Square is pleased to announce the placement of Melissa Bradford-Klug as Chief Business Officer at Citrine Medicine Ltd. Citrine Medicine is backed by Eight Roads Ventures, a global proprietary investment firm backed by Fidelity.

Bradford-Klug most recently served as Chief Business Officer at Keryx Biopharmaceuticals. Previously, she served as Senior Vice President, Strategy and Corporate Development at AMAG Pharmaceuticals. Earlier, she served in various roles at Mallinckrodt Pharmaceuticals, including Vice President, Corporate Development; Vice President, Strategy and Business Development and Licensing- Pharmaceutical Sector; Senior Director, Program Management and Portfolio Planning; and Director, Marketing- Brand Pharma. 

Bradford-Klug received her B.Sc. from Maryville University and her M.B.A. from DePaul University. 

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.